These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34581321)

  • 21. Photosensitive Pt(IV)-azide prodrug-loaded nanoparticles exhibit controlled drug release and enhanced efficacy in vivo.
    Xiao H; Noble GT; Stefanick JF; Qi R; Kiziltepe T; Jing X; Bilgicer B
    J Control Release; 2014 Jan; 173():11-7. PubMed ID: 24511610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective cancer therapy by extracellular activation of a highly potent glycosidic duocarmycin analogue.
    Chen KC; Schmuck K; Tietze LF; Roffler SR
    Mol Pharm; 2013 May; 10(5):1773-82. PubMed ID: 23448264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrophilic Azides for Materials Synthesis and Chemical Biology.
    Xie S; Sundhoro M; Houk KN; Yan M
    Acc Chem Res; 2020 Apr; 53(4):937-948. PubMed ID: 32207916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imaging beyond the diagnosis: image-guided enzyme/prodrug cancer therapy.
    Tong X; Chen X; Li C
    Acta Biochim Biophys Sin (Shanghai); 2011 Jan; 43(1):4-12. PubMed ID: 21134886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody directed enzyme prodrug therapy (ADEPT) and related approaches for anticancer therapy.
    Jung M
    Mini Rev Med Chem; 2001 Nov; 1(4):399-407. PubMed ID: 12369965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Duocarmycin-based prodrugs for cancer prodrug monotherapy.
    Tietze LF; Schuster HJ; Schmuck K; Schuberth I; Alves F
    Bioorg Med Chem; 2008 Jun; 16(12):6312-8. PubMed ID: 18524605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thiolation of protein-bound carcinogenic aldehyde. An electrophilic acrolein-lysine adduct that covalently binds to thiols.
    Furuhata A; Nakamura M; Osawa T; Uchida K
    J Biol Chem; 2002 Aug; 277(31):27919-26. PubMed ID: 12032148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medicinal chemistry of antiviral/anticancer prodrugs subjected to phosphate conjugation.
    Kalász H; Adem A; Hasan MY; Adeghate E; Ram N; Gulyás Z; Tekes K
    Mini Rev Med Chem; 2010 Aug; 10(9):822-45. PubMed ID: 20491651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enantioselective intermolecular formal [3 + 3] cycloaddition of 2,3-disubstituted indoles with acrolein.
    Huang J; Zhao L; Liu Y; Cao W; Wu X
    Org Lett; 2013 Sep; 15(17):4338-41. PubMed ID: 23947569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual Stimuli-Activatable Oxidative Stress Amplifying Agent as a Hybrid Anticancer Prodrug.
    Han E; Kwon B; Yoo D; Kang C; Khang G; Lee D
    Bioconjug Chem; 2017 Apr; 28(4):968-978. PubMed ID: 28192990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disease-associated acrolein: A possible diagnostic and therapeutic substrate for in vivo synthetic chemistry.
    Muguruma K; Pradipta AR; Ode Y; Terashima K; Michiba H; Fujii M; Tanaka K
    Bioorg Med Chem; 2020 Dec; 28(24):115831. PubMed ID: 33199202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The nitric oxide prodrug JS-K and its structural analogues as cancer therapeutic agents.
    Maciag AE; Saavedra JE; Chakrapani H
    Anticancer Agents Med Chem; 2009 Sep; 9(7):798-803. PubMed ID: 19538173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cisplatin Prodrug-Conjugated Gold Nanocluster for Fluorescence Imaging and Targeted Therapy of the Breast Cancer.
    Zhou F; Feng B; Yu H; Wang D; Wang T; Liu J; Meng Q; Wang S; Zhang P; Zhang Z; Li Y
    Theranostics; 2016; 6(5):679-87. PubMed ID: 27022415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An activatable prodrug for the treatment of metastatic tumors.
    Kim EJ; Bhuniya S; Lee H; Kim HM; Cheong C; Maiti S; Hong KS; Kim JS
    J Am Chem Soc; 2014 Oct; 136(39):13888-94. PubMed ID: 25238144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitrobenzyl carbamate prodrugs of enediynes for nitroreductase gene-directed enzyme prodrug therapy (GDEPT).
    Hay MP; Wilson WR; Denny WA
    Bioorg Med Chem Lett; 1999 Dec; 9(24):3417-22. PubMed ID: 10617083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enantio- and diastereoselective synthesis of duocarmycine-based prodrugs for a selective treatment of cancer by epoxide opening.
    Tietze LF; Schuster HJ; Hampel SM; Rühl S; Pfoh R
    Chemistry; 2008; 14(3):895-901. PubMed ID: 18033701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential role of acrolein in neurodegeneration and in Alzheimer's disease.
    Dang TN; Arseneault M; Murthy V; Ramassamy C
    Curr Mol Pharmacol; 2010 Jun; 3(2):66-78. PubMed ID: 20302565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo.
    Zhong Y; Goltsche K; Cheng L; Xie F; Meng F; Deng C; Zhong Z; Haag R
    Biomaterials; 2016 Apr; 84():250-261. PubMed ID: 26851390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Albumin-bound polyacrolein: implications for Alzheimer's disease.
    Seidler NW; Yeargans GS
    Biochem Biophys Res Commun; 2004 Jul; 320(1):213-7. PubMed ID: 15207723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in small molecule prodrugs for cancer therapy.
    Wang P; Jin X; Cai J; Chen J; Ji M
    Anticancer Agents Med Chem; 2014 Mar; 14(3):418-39. PubMed ID: 23869777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.